Xeris Biopharma Holdings Inc
XERS
Market Cap$752.73M
Close$
$2.89
38.1% downside
Current Fair Value
38.1% downsideOvervalued by 38.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $752.73 Million |
|---|---|
| Enterprise Value | $963.04 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.37 |
| Beta | 0.91 |
| Outstanding Shares | 152,445,935 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -15.9 |
|---|---|
| PEG | 30.91 |
| Price to Sales | 4.67 |
| Price to Book Ratio | -4.67 |
| Enterprise Value to Revenue | 4.35 |
| Enterprise Value to EBIT | -38.95 |
| Enterprise Value to Net Income | -22 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | -7.65 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Xeris Pharmaceuticals Inc
CEO: paul Edick